Person-centred care Psychosocial Self-management a b s t r a c t Aims: The Diabetes Attitudes Wishes and Needs 2 (DAWN2) study aims to provide a holistic assessment of diabetes care and management among people with diabetes (PWD), family members (FM), and healthcare professionals (HCPs) and explores potential drivers leading to active management. Methods: DAWN2 survey over 16,000 individuals (9000 PWD, 2000 FM of PWD, and 5000 HCPs) in 17 countries across 4 continents. Respondents complete a group-specific questionnaire; items are designed to allow cross-group comparisons on common topics. The questionnaires comprise elements from the original DAWN study (2001), as well as psychometrically validated instruments and novel questions developed for this study to assess self-management, attitudes/beliefs, disease impact/burden, psychosocial distress, health-related quality of life, healthcare provision/receipt, social support and priorities for improvement in the future. The questionnaires are completed predominantly online or by telephone interview, supplemented by face-to-face interviews in countries with low internet access. In each country, recruitment ensures representation of the diabetes population in terms of geographical distribution, age, gender, education and disease status.
Introduction
In 2001, the Diabetes, Attitudes, Wishes and Needs (DAWN) study showed that self-management of diabetes was considered poor by people with diabetes (PWD) and healthcare professionals (HCPs). Diabetes-related distress was common amongst PWD and hampered efforts to self-manage their condition, but few received psychological treatment [1] . Although recognition by HCPs of emotional problems and diabetes-specific distress amongst PWD was low, HCPs desired a better understanding of such issues [2] . Collaboration among diabetes care providers was identified as an important factor for improving diabetes outcomes, but interdisciplinary team care was uncommon [2] , and there was some resistance by PWD and HCPs to the timely initiation of effective therapies [3] .
Following DAWN, patient representatives and an interdisciplinary group of diabetes care experts discussed how the DAWN findings could be translated into improved diabetes care [4] . The resulting 'DAWN Call to Action' [5] encouraged multiple stakeholders (HCPs, PWD and their family members [FMs]/carers, payers, policy makers, industry and non-government organisations) to implement person-centred diabetes care, and actively involve PWD in self-management with support from an interdisciplinary team of HCPs [2] .
The DAWN findings support a paradigm shift from an acute care model to a person-centred, integrated chronic care model, such as the WHO Innovative Care for Chronic Conditions framework to diabetes [6] . This model involves care at three levels: micro, meso and macro, which refer to individual, healthcare organisation/community, and policy levels, respectively [6] . Optimal diabetes care is best achieved by collaboration between PWD, FM, community partners and healthcare teams that are informed, motivated, prepared, and able to work together. This collaboration is supported and influenced by the broader healthcare organisations and communities, and by the policy environment [6] . Scientific evidence provides the foundation for the approaches to care [6] , but the PWD perspective is important in informing all levels of healthcare [7] . PWD have the right to be informed and educated, to have access to proper diabetes care and optimal medicine, and not to be discriminated against because of their condition [8] .
It is a decade since the DAWN study highlighted the need for collaborative action across countries to improve selfmanagement and psychosocial support. Despite major advances in collaborative care many PWD still do not achieve desirable treatment outcomes. The growing burden of diabetes calls for stronger and broader globally-coordinated efforts. As more countries recognise the effect of diabetes on population health, and the economic and personal burdens, we must expand our knowledge to include the diverse social institutions and cultures of these countries. As our knowledge has advanced, we have identified gaps in our knowledge of the role of support from family and community in living with and caring for PWD. Across nations, there is a pressing need for a new global translational research initiative that can form the foundation for measurement-guided multi-stakeholder collaboration for the advancement of person-centred diabetes care world-wide. Thus, it is time for a new DAWN.
The DAWN2 study initiative, undertaken by Novo Nordisk in partnership with the International Diabetes Federation (IDF), the International Alliance of Patient Organisations (IAPO), the Steno Diabetes Center, and a range of other national, regional and global partners, aims to (a) improve our understanding of the unmet needs of PWD and their caretakers, (b) facilitate dialogue and collaboration among all key stakeholders to strengthen patient involvement and improve self-management and (c) establish a cross-culturally validated multi-national survey framework for assessing and benchmarking psychosocial and educational aspects of diabetes care delivery. The overall aim is to identify avenues for improvement at all three levels of care -at the meso and macro-levels for diabetes care funding and care provision, and at the micro level for delivery of care. The study explores how PWD, FMs and HCPs perceive diabetes care and investigates the value of a person-centred model of diabetes care that emphasises the needs of the individual in the context of current chronic care, self-management education and psychosocial support. This paper describes the study methodology.
2.
Materials and methods
Study objectives
Within a national and international setting, the predefined objectives of the DAWN2 study are:
Primary objective: To assess potential barriers to and facilitators of active and successful management of diabetes among PWD, FMs, and HCPs. Secondary objectives: To establish national benchmarks for health status, quality of life (QoL), access to self-management education and to self-care in diabetes.
To assess the access to, and use and benefit of, support from healthcare teams, family and friends, communities and society.
To explore and pinpoint the most important facilitators and barriers to person-centred chronic care for each stakeholder group.
To identify successes, wishes, needs, preferences and priorities for change among all key stakeholders in diabetes.
Study design
DAWN2 is a multinational, interdisciplinary and multistakeholder study designed in February 2011 to examine the experiences and unmet needs of PWD, FMs, and HCPs ( 
Ethical considerations
In each country, the study is being conducted in accordance with the relevant ethical requirements, following regional/ national/local guidelines relating to the conduct of noninterventional studies and uses guidelines of the International Chamber of Commerce/European Society for Opinion and Marketing Research [9] , the Council of American Survey Research Organizations [10] and Good Pharmacoepidemiology Practices [11] as a minimum standard.
Study participants
DAWN2 is being conducted in 17 countries: Algeria, Canada, China, Denmark, France, Germany, India, Italy, Japan, Mexico, The Netherlands, Poland, Russia, Spain, Turkey, United Kingdom (UK) and United States of America (USA). Brazil was originally included in the study plan, however due to timing issues, the DAWN2 study in Brazil will be conducted separately.
The participating countries represent 4 continents -Europe, Asia, North America, and Africa. Countries volunteered for participation in DAWN2, including providing study funding, mainly to identify ways to enhance diabetes care and the lives of PWD and their FM. Other countries are currently applying or planning to apply components of the DAWN2 study design as part of the wider DAWN network; however, these research activities are not part of the 17country DAWN2 study. Overall, the study population comprises 16,100 participants: 9040 PWD, 2160 FMs and 4900 HCPs. Inclusion/exclusion criteria are presented in Table 1 . Each country's sample is a minimum of 900 participants: 500 PWD, 120 FMs and 280 HCPs (see Fig. 1 ). In the USA, an additional sample of 540 PWD and 120 FMs of African-American, Hispanic and Asian ethnic origin and 140 HCPs who treat minority populations is included to obtain adequate numbers for subgroup analyses. In general, the three participant groups are independent (e.g., participants in PWD sample are not treated by participants in HCP sample). However, for the FM sample, some of the 120 participants do live in the same household as individuals who participated in the PWD survey. The data for these participants enables linkage between this subset of PWD and their FMs.
The HCP sample comprises specialist physicians (endocrinologists and diabetologists), primary care (PC) providers, general practitioners (GPs) and internal medicine physicians (with a sub-speciality in diabetes) and other HCPs (e.g., diabetes nurses, dietitians, diabetes educators, counsellors or physician's assistants, who vary by country). The sample of PWD predominantly comprises those with type 2 diabetes (with quotas for different treatment regimens), but also includes participants with type 1 diabetes.
The global study sample (and subsample) sizes are sufficient to achieve more than 80% power for a 'small' effect size (e.g., Cohen's d = 0.2). National samples of PWD and HCP were designed to achieve 80% power for a 'medium' effect size (e.g., Cohen's d = 0.5). Minimum national sample size was 120 to achieve 80% power to detect a difference in proportions of 10%. Minimum national subsample size was 80 to permit effective weighting (especially important when proportional sampling would generate a smaller subsample that would not yield a reliable subsample estimate).
2.5.
Recruitment methodology
HCPs
In all countries, potential participants are identified primarily from online panels and databases. When necessary, other sources such as telephone lists and physician directories are used for recruitment. All potential participants are invited to take part via email or phone. As with other DAWN2 survey groups, all participants receive a weblink to a secure server to enable them to complete the survey online.
PWD and FMs
Web, telephone and in-person methods relevant to each country's situation were applied while trying to maximise comparability of methodologies and survey populations across countries. Table 1 -Inclusion and exclusion criteria.
Inclusion criteria
All participants: Internet access at home or convenient location or able to attend a face-to-face or telephone interview; informed consent before the start of any study-related activities PWD: Adults aged 18 years diagnosed with diabetes by an HCP at least 12 months ago (type 1 or type 2; not only during pregnancy) FM: Adults aged 18 years who are not diagnosed with diabetes, live in the same household with an adult (18 years) with diabetes (type 1 or type 2; not only during pregnancy) and are involved in his/her care HCP: GPs, PC physicians and internal medicine physicians who have been in practice for 1 year and who personally treat 5 adults (18 years) with diabetes per month and initiate oral medication HCP: Diabetes specialists (endocrinologists/diabetologists or GP/PC physicians/internal medicine physicians with sub-speciality in diabetes) who have been in practice for 1 year, personally treat 50 adults (18 years) with diabetes per month and prescribe insulin (may also prescribe oral medication or other injectable diabetes medications). Threshold may be adjusted according to country-specific requirements HCP: Other HCPs (diabetes nurses/dietitians/other HCPs) who have been in their respective professions for 1 year and provide care for 5 adults (18 years) with diabetes per month Exclusion criteria
All participants: Inability to understand and comply with written and verbal instructions PWD: Individuals aged <18 years and/or diagnosed with diabetes less than 12 months ago and/or diagnosed with diabetes only during pregnancy FM, family members; GPs, general practitioners; HCP, healthcare professional; PC, primary care; PWD, people with diabetes.
Hybrid online and telephone methodology
In 11 DAWN2 countries with high internet penetration (USA, Canada, UK, France, Germany, Italy, Spain, Denmark, Netherlands, Poland, Japan) a hybrid online and telephone methodology is used to recruit PWD and FMs. In these groups, participants are enrolled using web-based recruitment or by telephone. This recruitment methodology is intended to ensure the study population in these countries is as representative as possible of the wider diabetes community and to address concerns regarding potential bias if the entire sample were obtained through web-based recruitment. For the online sample, potential participants are identified from multiple online panels and databases per country. Individuals identified from these sources are contacted by email and invited to participate in the study. Participants recruited by telephone may complete the survey either by telephone or online. Depending on their preference, participants are either sent a web-link via email to complete the survey online or are interviewed by telephone.
For the telephone sample, potential participants are identified from a variety of sources (general telephone lists, proprietary databases, lists from past research, patient association lists). They are contacted by telephone and, if eligible, invited to participate in the study. Procedural details for non-web-based recruitment are country-specific and comply with local logistics and ethical regulations.
Face-to-face-methodology
In the remaining six DAWN2 countries with lower internet access (Algeria, China, India, Mexico, Russia and Turkey) participants are recruited by telephone or face-to-face using telephone lists, patient association lists, proprietary databases, and hospital and physician directories. Participants complete the questionnaire via a face-to-face interview.
Questionnaires
The multi-dimensional scientific survey design for DAWN2 was developed by the Global DAWN2 Survey Working Group according to a person-centred model for chronic illness care with input from multi-national, multi-disciplinary meetings involving representatives of all the countries participating in DAWN2, and patient advocacy and scientific experts from the collaborating organisations. A summary of the main topics and subtopics covered by the PWD, FM, and HCP questionnaires is presented in Table 2 . The questionnaires were designed to permit comparison across respondent types where possible. The questionnaires incorporate several elements, including: items from the original DAWN study (to enable evaluation of trends in diabetes care over the past decade); newly developed questions (to investigate areas such as discrimination and the needs and preferences for better education and support); and open-ended questions (to capture the individual stories of the respondents). Some new questions were developed with inspiration from, or adapted/modified from existing validated instruments, as relevant in each case with the originators of the questionnaires, including the Diabetes Empowerment Scaleshort form (DES-SF) [12, 13] ; Diabetes Family Behavior Checklist (DFBC) [14] and the Health Care Climate Questionnaire (HCC) [15] . In addition, several standardised instruments were incorporated into the questionnaires in original or shortened forms, including: the Problem Areas in Diabetes-short form (PAID-5) [12] [13] [14] [15] [16] [17] [18] [19] [20] ; Patient Assessment of Chronic Illness Care (PACIC) [16, 17] ; Summary of Diabetes Self-Care Activities Measure (SDSCA) [21] ; WHOQOL-BREF [22] ; EuroQol (EQ-5D) [23] ; and the WHO Well-Being Index (WHO-5) [24] . Family and social support Non-HCP support behaviours (modified DFBC); non-HCP involvement; reasons for non-involvement; living situation; family conflict; overall social support Non-HCP support behaviours (modified DFBC); non-HCP involvement; reasons for non-involvement; living situation; family conflict; split of responsibilities; overall social support; assistance with hypoglycaemia Importance of family involvement d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 9 9 ( 2 0 1 3 ) 1 7 4 -1 8 4 All surveys were reviewed and approved in the original English version by leading experts from all participating countries. The three survey questionnaires in English were tested further with 16 participants (7 PWD, 3 FMs and 6 HCPs) from India, Canada, USA, and the UK, to assess whether the questionnaire content was unambiguous and understandable and to ensure face validity and acceptability. Questionnaires were subjected to additional written reviews by people with type 1 and type 2 diabetes prior to finalisation.
Questionnaires for the three surveys were translated into the primary language(s) of each participating country by at least two independent local professional translators who were native speakers in the relevant local language. These translations were reviewed by national diabetes experts in each country to confirm the accuracy and cross-cultural equivalence of the translations. A subset of selected psychometrically validated scales and items intended for scientific benchmarking within and across countries were back translated into English by a third independent professional translator and a review and harmonisation process was undertaken. This involved the approval by academic experts and originators of the original scientific scales, as well as PWD, where feasible. This process also involved multi-national harmonisation of previously published local language versions of scientific instruments, including the PAID-5, the WHO-5, the WHOQOL-Bref and the SDSCA.
Research questions
The DAWN2 surveys were designed to provide data-driven guidance relevant for all stakeholders in diabetes and chronic illness management regarding how diabetes care may be optimised locally, nationally or internationally at the micro, meso or macro level within a holistic person-centred chronic care framework. Key research questions include:
1. How do the participating countries compare in terms of healthcare processes and outcomes based on the measures that are proposed as suitable for benchmarking (e.g., established validity and reliability of source measures)? 2. What are the determinants of QoL and psychosocial adaptation of PWD? 3. What are the determinants of self-management behaviour by PWD? 4. What are the determinants of HCP delivery of personcentred diabetes care/support (especially those forms of care/support that are found to have a major impact on patient outcomes)? 5. What are the determinants of burden for FMs and family support for PWD, especially those forms of support that are found to have a major impact on patient outcomes? 6. What is the current level of access to diabetes education, how is it provided, and what are the benefits to PWD? What are the roles of nurses, dietitians and other HCP providers? 7. What are the determinants of medication initiation, adherence, persistence and intensification? 8. What changes have occurred in the period between DAWN and DAWN2? 9. What are the key events that have created turning-points in how people live with and manage diabetes? What individual and societal changes do survey respondents want?
Numerous additional topics will be addressed, but a full listing of questions is beyond the scope of this paper.
Supplementary research
In parallel with the three main surveys, a separate situational assessment is being performed in each country, comprising literature research on national guidelines, policies and activities related to person-centred diabetes care, supplemented by interviews with a range of different national stakeholders. These are designed to provide an assessment of the existing diabetes and chronic care delivery systems in each country, against which the perceptions of survey respondents can be compared. Representatives of patient associations, policy-makers and thought leaders in each country are key contributors to this study component. The situational assessment allows each country to benchmark itself relative to other countries in relation to health policies, guidelines, healthcare infrastructures, national programmes, and community structures related to person-centred chronic illness care, and to identify concrete opportunities for national improvement from the DAWN2 survey results.
Analysis
Survey data are provided to the Principal Investigators of each country's national advisory or survey group as descriptive statistics for all variables for each participant group. To permit generalisation from the sample to larger populations, individual weights are provided. These weights are based on population proportions for each country, as provided by each country's survey advisory group, and on publicly available epidemiological data. Furthermore, the subset of FMs who live in the same household as individuals who complete the PWD questionnaire are linked to one another for analysis. This enables comparison of the perceptions of provision of practical and emotional care and support from both members of the dyad and assessment of the association between the behaviour of support givers and the impact on support recipients. For non-linked samples, concordance between respondents can be assessed statistically for items that are identical, but other items can only be compared numerically (e.g., the percentage of PWD who report engaging in a behaviour and the percentage of PWD that physicians estimate to engage in that behaviour).
Publications will use the appropriate statistical tests for a particular hypothesis and type of data. These include nonparametric bivariate statistics (e.g., chi-squared test, Kendall correlation coefficient, Mann-Whitney test, Kruskal-Wallis test), parametric bivariate statistics (e.g., analysis of variance, Pearson correlation) and multivariate tests (e.g., logistic regression, ordinary least squares regression, analysis of covariance).
In addition, psychometric validation of multi-item measures in each country will be performed to confirm crosscultural validity and suitability for clinical and benchmarking purposes.
Discussion
The 'DAWN Call to Action' [5] identified strategic areas for the improvement of diabetes care by focusing on the psychosocial issues attached to living with diabetes [2, 5] . Strategies for national action to improve access to person-centred diabetes care, as guided by the first DAWN study, included: (1) raising awareness of the PWD perspective, (2) empowerment of PWD through information and education, (3) training of HCPs, (4) development of innovative tools to deliver PWD support, (5) improvement of guidelines/policies for person-centred care, and (6) translational research into delivery of person-centred diabetes care. Evidence suggests that substantial progress has been made within these areas, but there is a need for continued implementation of these strategies, including training of HCPs in person-centred chronic illness care [25, 26] , new tools and intervention strategies for improving the psychosocial care of PWD [2, 27] , revision of guidelines to include sections on the self-management and psychosocial aspects of diabetes care [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] , and research on psychosocial and person-centred diabetes care [40] .
DAWN2 builds upon a decade of multi-nationally coordinated actions and efforts to improve person-centred care. Following DAWN, other diabetes surveys have been initiated to explore psychosocial issues in diabetes, but predominantly in relation to medical therapy and not addressing FM, community, or patient organisation perspectives.
The scope of DAWN2 is broad and should further our understanding of issues in diabetes and person-centred care, over and above that provided by other diabetes surveys. By surveying the attitudes, wishes and needs of over 16,000 people from the three stakeholder groups involved in day-today living with and management of diabetes, DAWN2 aims to provide a unique, comprehensive, systematic perspective on the facilitators and barriers to achieving optimal personcentred diabetes care.
The design of the DAWN2 questionnaires should enable identification of discrepancies between the 'felt needs' of PWD and their 'perceived needs' by FMs and HCPs. Comparisons of the results across countries, within the context of differing national guidelines, policies and care delivery models, may identify optimal and sub-optimal national and local models of care, education and community support. Through the crosscultural validation of the multiple scientific measurement instruments incorporated into the DAWN2 survey, each country can incorporate mini-DAWN2 surveys into clinic, local, and regional quality improvement programmes, to allow for within-country benchmarking.
Comparison of DAWN2 data with those from DAWN allows for the determination of temporal trends in the profile of diabetes care and, possibly, whether differences between these data in countries that participated in both studies reflect a growing recognition and acceptance of the psychosocial aspects of diabetes care in the past 10 years.
Study limitations
Many challenges are associated with conducting DAWN2, the largest multi-national study of its kind in diabetes, including how to represent the population within each country accurately. Since DAWN2 aims to study variations in access to and consequences of diabetes care, community support and education within and between countries, samples needed to be geographically and socio-demographically dispersed in each country. Therefore, recruiting through a limited number of centres or clinics, as often done in diabetes surveys for practical reasons, would not be appropriate for DAWN2 as results would be biased towards well-resourced clinics.
While populations with internet access may be generally representative of the total population in some countries, internet methodology may not be fully representative. Phone recruitment was used to some extent in all countries to minimise a systematic bias related to internet use only. Moreover, weighting of the data from each country to national proportions should help minimise such biases. However, in some countries, telephone penetration is poor. While the use of face-to-face recruitment and interviewing in the DAWN2 study helps overcome this barrier to representativeness, the expense associated with outreach to rural areas in countries with broad geographic dispersion makes sampling of all areas of the country infeasible. In addition, some countries and regions are not represented, e.g., Indonesia, Thailand, the Arab countries, sub-Saharan Africa and South America. Thus, results cannot be generalised to the entire global population of the three key diabetes stakeholder groups.
Conclusions
The original DAWN study identified a major gap between the psychosocial and educational support needs of PWD, and the care and support available in developed and less developed countries. However, despite developments in the field of selfmanagement education and psychosocial care during the past decade, too many PWD receive inadequate care and support to enable them to achieve optimal health and well-being. In response, DAWN2 seeks to identify possible areas for improvement and determine the drivers of change to achieve optimal person-centred diabetes care. DAWN2 has been designed to facilitate easy translation of the study findings, including involvement of a broad foundation of multiple national and international diabetes stakeholders.
As the first major survey of the opinions of FMs of PWD, DAWN2 aims to achieve a broader humanistic and societal perspective on the needs of PWD and those caring for them. Responding to the IDF declaration on patients' rights and responsibilities, and including all areas of life with diabetes, it is hoped that DAWN2 will promote improvements in conditions for PWD. Ultimately, DAWN2 aspires to provide a voice for PWD and those caring for them, which reflects their unmet needs.
The DAWN2 study should enable new opportunities for improving diabetes self-management and QoL, and for ascertaining the critical drivers of active management as well as improvement in person-centred diabetes care. These findings may facilitate innovative efforts by all stakeholders to improve self-management and psychosocial support in diabetes.
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